Market›Health Care›Health Care Equipment & Supplies›Health Care Supplies
INSPIREMD INC EQUITY Equity

NSPR

$1.25Apr 26, 2021 – Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Supplies$62M
MVM
-$2.3M
TD Variance
-0.612

Every news event mapped to its market reaction — 102 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2023-05-15+16.2%legalSEC EDGARNSPR 8-K: 1.01, 3.02, 7.01 (SEC Filing)
2025-07-31+15.5%newsSeeking AlphaInspireMD raises $58M through combined financings; shares up
2025-07-31+15.5%legalSEC EDGARNSPR 8-K: 1.01, 3.02, 5.02, 7.01, 8.01 (SEC Filing)
2024-11-25+13.1%legalSEC EDGARNSPR 8-K: 5.02, 7.01 (SEC Filing)
2022-11-08-12.4%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2025-06-24-12.3%legalSEC EDGARNSPR 8-K: 7.01, 8.01 (SEC Filing)
2021-07-26-12.0%legalSEC EDGARNSPR 8-K: 8.01 and (SEC Filing)
2026-03-03-11.8%earningsZacksNeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates
2025-04-25-11.5%newsStock TitanNSPR Stock Price, News & Analysis - Stock Titan
2023-06-26+11.0%legalSEC EDGARNSPR 8-K: 7.01, 8.01 (SEC Filing)
2026-03-17+10.3%earningsSeeking AlphaInspireMD Q4 2025 Earnings Preview
2025-08-04-9.9%earningsSeeking AlphaInspireMD Q2 2025 Earnings Preview
2021-05-12-9.8%legalSEC EDGARNSPR 8-K: 5.02, 8.01 (SEC Filing)
2022-05-20-7.2%legalSEC EDGARNSPR 8-K: 8.01 (SEC Filing)
2023-10-06-7.2%legalSEC EDGARNSPR 8-K: 5.02 and (SEC Filing)
2025-11-04-7.0%earningsSeeking AlphaInspireMD, Inc. (NSPR) Q3 2025 Earnings Call Transcript
2025-11-04-7.0%earningsSeeking AlphaInspireMD GAAP EPS of -$0.17
2025-11-04-7.0%legalSEC EDGARNSPR 8-K: 2.02, 7.01 (SEC Filing)
2026-04-08-6.7%newsZacksAfter Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)
2026-04-08-6.7%earningsMarketBeatInspireMD (NYSE:NSPR) Trading Down 6.7% - What's Next? - MarketBeat
2024-04-02-6.6%legalSEC EDGARNSPR 8-K: 5.02 and (SEC Filing)
2025-08-05-6.6%earningsSeeking AlphaInspireMD, Inc. 2025 Q2 - Results - Earnings Call Presentation
2025-08-05-6.6%expansionSeeking AlphaInspireMD signals robust U.S. CGuard Prime launch progress and expands clinical pipeline following $58M capital infusion
2025-08-05-6.6%earningsSeeking AlphaInspireMD, Inc. (NSPR) Q2 2025 Earnings Call Transcript
2025-08-05-6.6%earningsSeeking AlphaInspireMD GAAP EPS of -$0.26, revenue of $1.78M misses by $0.02M
2025-08-05-6.6%legalSEC EDGARNSPR 8-K: 2.02, 7.01 (SEC Filing)
2023-11-06-6.6%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2024-07-01-6.5%legalSEC EDGARNSPR 8-K: 7.01, 8.01 (SEC Filing)
2024-09-16-6.4%legalSEC EDGARNSPR 8-K: 7.01, 8.01 (SEC Filing)
2024-12-12-6.4%executiveSeeking AlphaInspireMD CFO Craig Shore to retire
2024-12-12-6.4%legalSEC EDGARNSPR 8-K: 5.02, 7.01 (SEC Filing)
2024-05-14-5.9%earningsSeeking AlphaInspireMD Inc. (NSPR) Q1 2024 Earnings Call Transcript
2024-05-14-5.9%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2025-11-27-5.8%newsYahoo FinanceIs InspireMD (NASDAQ:NSPR) In A Good Position To Invest In Growth? - Yahoo Finance
2024-10-15-5.7%legalSEC EDGARNSPR 8-K: 1.01, 7.01 (SEC Filing)
2022-06-03-5.5%legalSEC EDGARNSPR 8-K: 1.01 and (SEC Filing)
2022-02-28+5.3%legalSEC EDGARNSPR 8-K: 8.01 and (SEC Filing)
2023-12-20-5.1%legalSEC EDGARNSPR 8-K: 7.01, 8.01 (SEC Filing)
2026-03-31-4.9%newsGlobeNewswireInspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference
2023-05-16-4.9%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2025-12-19+4.8%legalSEC EDGARNSPR 8-K: 5.02 and (SEC Filing)
2024-11-11+4.6%earningsSeeking AlphaInspireMD Q3 2024 Earnings Preview
2023-11-01-4.5%legalSEC EDGARNSPR 8-K: 7.01, 8.01 (SEC Filing)
2025-05-09-3.9%earningsSeeking AlphaInspireMD outlines Q3 2025 FDA approval target for CGuard Prime
2025-05-09-3.9%earningsSeeking AlphaInspireMD, Inc. (NSPR) Q1 2025 Earnings Call Transcript
2025-05-09-3.9%earningsSeeking AlphaInspireMD GAAP EPS of -$0.22, revenue of $1.53M beats by $0.08M
2025-05-09-3.9%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2025-04-01-3.9%legalSeeking AlphaInspireMD files $200M mixed securities shelf
2023-03-30-3.7%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2026-04-03-3.7%legalSEC EDGARNSPR 8-K: 1.01, 8.01 (SEC Filing)
2026-04-03-3.7%expansionStock TitanInspireMD (NSPR) sets $75M BTIG equity distribution agreement - Stock Titan
2026-04-03-3.7%newsTipRanksInspireMD Establishes New $75 Million ATM Program - TipRanks
2025-03-12+3.7%earningsSeeking AlphaInspireMD, Inc. (NSPR) Q4 2024 Earnings Call Transcript
2025-03-12+3.7%earningsSeeking AlphaInspireMD GAAP EPS of -$0.19, revenue of $1.95M
2025-03-12+3.7%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2026-03-04-3.7%legalSEC EDGARNSPR 8-K: 5.02 and (SEC Filing)
2021-05-11+3.6%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2024-08-06-3.6%earningsSeeking AlphaInspireMD GAAP EPS of -$0.22, revenue of $1.74M
2024-08-06-3.6%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2021-11-04-3.6%legalSEC EDGARNSPR 8-K: 8.01 and (SEC Filing)
2024-12-09+3.4%legalSEC EDGARNSPR 8-K: 7.01, 8.01 (SEC Filing)
2023-07-21+3.1%legalSEC EDGARNSPR 8-K: 5.02 and (SEC Filing)
2025-07-11-3.1%expansionYahoo FinanceInspireMD Launches CGuard Prime Carotid Stent System in the U.S. - Yahoo Finance
2021-08-10-2.9%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2026-03-18-2.8%earningsGuruFocus.comInspireMD Inc (NSPR) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advancements
2026-03-18-2.8%earningsZacksInspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates
2026-03-18-2.8%newsGlobeNewswireInspireMD Reports Fourth Quarter and Full Year 2025 Financial Results
2026-03-18-2.8%earningsSeeking AlphaInspireMD targets $13M–$15M in 2026 revenue as CGuard Prime gains U.S. traction
2026-03-18-2.8%earningsSeeking AlphaInspireMD, Inc. (NSPR) Q4 2025 Earnings Call Transcript
2026-03-18-2.8%earningsSeeking AlphaInspireMD GAAP EPS of -$0.14, revenue of $3.15M beats by $0.52M
2026-03-18-2.8%legalSEC EDGARNSPR 8-K: 2.02, 7.01 (SEC Filing)
2026-03-18-2.8%newsStock TitanStroke stent maker InspireMD lifts sales 62% and targets up to $15M in 2026 - Stock Titan
2024-01-31-2.7%legalSEC EDGARNSPR 8-K: 7.01, 8.01 (SEC Filing)
2022-03-08+2.7%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2025-11-03-2.6%earningsSeeking AlphaInspireMD Q3 2025 Earnings Preview
2021-09-30+2.5%legalSEC EDGARNSPR 8-K: 5.02 and 5.07 (SEC Filing)
2022-05-10-2.5%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2024-08-05+2.4%earningsSeeking AlphaInspireMD Q2 2024 Earnings Preview
2024-11-12+2.3%earningsSeeking AlphaInspireMD, Inc. (NSPR) Q3 2024 Earnings Call Transcript
2024-11-12+2.3%earningsSeeking AlphaInspireMD GAAP EPS of -$0.16, revenue of $1.81M beats by $0.07M
2024-05-31+2.1%legalSEC EDGARNSPR 8-K: 1.01, 8.01 (SEC Filing)
2024-10-01-2.1%legalSEC EDGARNSPR 8-K: 5.02 and (SEC Filing)
2021-10-13+2.0%legalSEC EDGARNSPR 8-K: 8.01 and (SEC Filing)
2024-10-07+1.9%legalSEC EDGARNSPR 8-K: 7.01 and 8.01 (SEC Filing)
2025-06-13-1.8%legalSEC EDGARNSPR 8-K: 7.01, 8.01 (SEC Filing)
2025-06-03+1.8%executiveSeeking AlphaInspireMD appoints Michael Lawless CFO
2025-06-03+1.8%legalSEC EDGARNSPR 8-K: 5.02, 7.01 (SEC Filing)
2026-03-15-1.6%newsSeeking AlphaQuant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag
2025-05-08+1.4%earningsSeeking AlphaInspireMD Q1 2025 Earnings Preview
2025-09-08+1.2%legalSEC EDGARNSPR 8-K: 5.02 (SEC Filing)
2022-08-11-1.2%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2024-03-06-1.1%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2023-08-08+1.1%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2024-08-09-0.8%earningsSeeking AlphaInspireMD, Inc. (NSPR) Q2 2024 Earnings Call Transcript
2026-03-09-0.7%newsGlobeNewswireInspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results
2023-03-20-0.6%legalSEC EDGARNSPR 8-K: 5.02, 7.01 (SEC Filing)
2026-04-20-0.6%newsStock TitanInspireMD (NSPR) schedules 2026 shareholder meeting on director slate and share authorization - Stock Titan
2021-11-09-0.3%legalSEC EDGARNSPR 8-K: 2.02 and (SEC Filing)
2024-05-28+0.2%legalSEC EDGARNSPR 8-K: 7.01, 8.01 (SEC Filing)
2025-09-17+0.1%legalSEC EDGARNSPR 8-K: 5.02, 7.01 (SEC Filing)
2025-01-21-0.0%newsStock TitanInspireMD Awards Strategic Employee Stock Grants to Accelerate Growth, Adds 9 New Hires - Stock Titan
2026-04-24—executiveStock TitanInspireMD (NSPR) CEO Marvin Slosman reports 5.18% beneficial stake - Stock Titan
tickerdossier.comtickerdossier.substack.com